Dr. Sithisarn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Rose St
Lexington, KY 40536Phone+1 859-323-1850
Education & Training
- University of Louisville School of MedicineResidency, Pediatrics, 2005 - 2007
- University of Kentucky College of MedicineFellowship, Neonatal-Perinatal Medicine, 2002 - 2005
- Chulalongkorn University Faculty of MedicineClass of 1997
Certifications & Licensure
- KY State Medical License 2005 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Neonatal-Perinatal Medicine
Clinical Trials
- Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach Start of enrollment: 2024 Mar 25
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Neonatal Abstinence Signs during Treatment: Trajectory, Resurgence and Heterogeneity.Jennifer S Miller, Henrietta S Bada, Philip M Westgate, Thitinart Sithisarn, Markos Leggas
Children. 2024-02-05 - 1 citationsUnderstanding the effects of opioids vs non-opioids in the treatment of neonatal abstinence syndrome, an in vitro model.Thitinart Sithisarn, Sandra J Legan, Philip M Westgate, Henrietta S Bada, Melinda E Wilson
Frontiers in Pediatrics. 2022-01-01 - 9 citationsPlasma Brain-Derived Neurotrophic Factor Levels in Newborn Infants with Neonatal Abstinence Syndrome.Lochan Subedi, Hong Huang, Amrita Pant, Philip M. Westgate, Henrietta S. Bada
Frontiers in Pediatrics. 2017-11-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: